2992 Results
193 Clinical Trials
Combination Therapy for Recurrent Ovarian Cancer
Study Type: Interventional / Phase: Phase 1
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Study Type: Interventional
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
Study Type: Interventional / Phase: Phase 1
A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors
Study Type: Interventional / Phase: Phase 1
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
Study Type: Interventional / Phase: Phase 1
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
Study Type: Interventional / Phase: Phase 1
ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors
Study Type: Interventional / Phase: Phase 1
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
Study Type: Interventional / Phase: Phase 2

Filter Results

Apply Filters Reset
+ Distance:
+ Study Type:
+ Phase:

Billiards Legend Jeanette Lee, 52, Survives Heart Attack amid Ovarian Cancer Fight: ‘God Gave Me More Time and I’m So Thankful!’

New Hope for Ovarian Cancer: FDA Approves Targeted Drug ELAHERE for Certain Patients With Difficult-to-Manage Disease

Tennis Legend, 69, Is Doing Peloton During Chemo For Ovarian Cancer Recurrence– Exercise Reduces Terrible Side Effects

Living
Living

‘It’s Hard to Watch’ – Tennis Great Pete Sampras’ Wrenching Journey Supporting Wife Bridgette, 50, Through Ovarian Cancer Battle

Recurrence
Recurrence

Elahere Is a Promising New Drug for Treating Advanced Ovarian Cancer. Is It Right For You?

Recurrence
Recurrence

From Diagnosis To Treatment: Understanding Hard-to-Treat Ovarian Cancer That is ‘Folate Receptor-Positive’

Recurrence
Recurrence

The New Drug Elahere Offers Hope in Ovarian Cancer That Has Stopped Responding to Chemotherapy

Recurrence
Recurrence

If Your Ovarian Cancer Has Returned and Stopped Responding to Treatment – You’ve Got Some New Options

Recurrence
Recurrence

A Comprehensive Guide to an Advanced Form of Ovarian Cancer Known as ‘Folate Receptor-Alpha Positive’

Recurrence
Recurrence

The New Drug Elahere is Providing Hope For a Hard-To-Treat Form of Ovarian Cancer Known as ‘Platinum-Resistant’

Recurrence
Recurrence

If You’ve Been Diagnosed With Hard-To-Treat Ovarian Cancer — The New Drug Elahere May Help

Recurrence
Recurrence

Elahere: A New Treatment Providing Hope When Ovarian Cancer Returns and Stops Responding to Treatment

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.